These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23224462)

  • 1. Improvements in micturition and urinary retention after switching from amisulpiride to paliperidone in a schizophrenic patient.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E11-2. PubMed ID: 23224462
    [No Abstract]   [Full Text] [Related]  

  • 2. Using paliperidone as a monotherapeutic agent on a schizophrenic patient with cirrhosis of the liver.
    Chou HW; Chen CL
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E37. PubMed ID: 23487226
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of paliperidone in a clozapine-resistant schizophrenic patient.
    Hsieh TH; Liu CT
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E36. PubMed ID: 23686056
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent hiccups associated with switching from paliperidone to amisulpride.
    Cheng CM; Tsai SJ
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):383. PubMed ID: 25210776
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E18. PubMed ID: 21948908
    [No Abstract]   [Full Text] [Related]  

  • 6. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible neuroleptic malignant syndrome associated with paliperidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):477-8. PubMed ID: 18070861
    [No Abstract]   [Full Text] [Related]  

  • 8. Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation.
    Kandasamy A
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E17-8. PubMed ID: 23037663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder].
    Bellantuono C; Santone G
    Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 11. Paliperidone: An improvement over risperidone?
    Dopheide JA
    Am J Health Syst Pharm; 2008 Mar; 65(5):401. PubMed ID: 18281730
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
    Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
    Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics.
    Schreiner A; Lahaye M; Peuskens J; Naber D; Dilbaz N; Millet B; Franco MA; Rancans E; Turczynski J; Smeraldi E; Lara E; Neznanov NG
    Expert Opin Pharmacother; 2014 Apr; 15(5):593-603. PubMed ID: 24491033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical guidelines on the use of paliperidone palmitate in schizophrenia.
    Newton R; Hustig H; Lakshmana R; Lee J; Motamarri B; Norrie P; Parker R; Schreiner A
    Curr Med Res Opin; 2012 Apr; 28(4):559-67. PubMed ID: 22321007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paliperidone-related Pisa syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):129-31. PubMed ID: 23288235
    [No Abstract]   [Full Text] [Related]  

  • 17. Paliperidone (Invega) for schizophrenia.
    Med Lett Drugs Ther; 2007 Mar; 49(1256):21-3. PubMed ID: 17351558
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating residual insomnia in schizophrenia: examining the options.
    Andrade C; Suresh Kumar PN
    Acta Psychiatr Scand; 2013 Jan; 127(1):11. PubMed ID: 23240596
    [No Abstract]   [Full Text] [Related]  

  • 19. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 20. Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.
    Maia-de-Oliveira JP; Nunes EA; Ushirohira JM; Machado-de-Sousa JP; Bressan RA; Hallak JE
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e14-6. PubMed ID: 25716490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.